Form 4: Perrigo CEO Patrick Lockwood-Taylor Reports Share Acquisition and Disposal

Sentiment:

SEC Form 4 Filing


Perrigo CEO Patrick Lockwood-Taylor reports acquisition of shares through vesting of restricted stock units and disposal of shares to cover tax obligations.

Summary

  • On March 7, 2025, Perrigo CEO Patrick Lockwood-Taylor reported acquiring 16,389 ordinary shares at a price of $27.76 per share due to the vesting of performance-based restricted stock units granted on July 10, 2023.
  • He also reported disposing of 5,925 ordinary shares at $27.76 per share.
  • Following these transactions, Lockwood-Taylor directly owns 55,873 ordinary shares.
  • Additionally, he was granted 23,454 Restricted Stock Units on March 6, 2025, which vest in two equal annual installments beginning March 6, 2026.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document primarily reports routine transactions related to executive compensation. The vesting of shares is a positive sign of performance, but the disposal of shares is a neutral event, likely for tax purposes.

Positives

  • The vesting of performance-based restricted stock units suggests that performance targets were met, which is a positive indicator.
  • The CEO's continued direct ownership of 55,873 ordinary shares demonstrates a continued investment in the company.

Negatives

  • The disposal of 5,925 shares, while likely for tax obligations, could be perceived negatively by some investors if not understood in context.

Risks

  • There are no specific risks mentioned in this document.
  • However, any significant disposal of shares by a key executive could create uncertainty among investors.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule of the restricted stock units indicates continued alignment of the CEO's interests with the company's performance through March 2026.

Industry Context

Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions. The vesting of restricted stock units is a common practice to incentivize and retain key executives.

Comparison to Industry Standards

  • Executive compensation packages often include restricted stock units that vest over time, aligning executive interests with long-term shareholder value.
  • The specific vesting schedule and performance metrics tied to these units vary across companies and industries.
  • Comparing Perrigo's executive compensation structure to peers like Teva, Mylan (now Viatris), and other generic pharmaceutical companies would provide a more detailed benchmark.

Stakeholder Impact

  • Shareholders may view the vesting of restricted stock units as a positive sign of management performance.
  • Employees may see this as a reflection of the company's overall success.

Key Dates

DateDescription
July 10, 2023Date of grant for performance-based restricted stock units that vested.
March 06, 2025Date of grant for 23,454 Restricted Stock Units.
March 07, 2025Date of share acquisition and disposal.
March 10, 2025Date of signature on the Form 4 filing.
March 06, 2026Start date for vesting of the 23,454 Restricted Stock Units in two equal annual installments.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.